Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis
dc.article.end-page | 11 | en |
dc.article.start-page | 1 | en |
dc.citation.doi | 10.1016/J.RPTH.2023.100077 | en |
dc.contributor.author | S Pipe | en |
dc.contributor.author | Ben Trzaskoma | en |
dc.contributor.author | Miranda Minhas | en |
dc.contributor.author | M Lehle | en |
dc.contributor.author | Johnny Mahlangu | en |
dc.contributor.author | E et al | en |
dc.date.accessioned | 2024-07-23T05:58:39Z | |
dc.date.available | 2024-07-23T05:58:39Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 2475-0379 | en |
dc.identifier.uri | https://hdl.handle.net/10539/39402 | |
dc.journal.title | Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis | en |
dc.journal.volume | 7 | en |
dc.publisher | WILEY-BLACKWELL | en |
dc.title | Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 1.07 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client